RIL
RIGL icon

Rothschild Investment LLC’s Rigel Pharmaceuticals RIGL Stock Holding History

Rothschild Investment LLC’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03K Buy
52
+51
+5,100% +$1.57K ﹤0.01% 2759
2026
Q1 		$27 Sell
1
-7
-88% -$235 ﹤0.01% 3522
2025
Q4 		$343 Buy
+8
New +$302 ﹤0.01% 3017
2025
Q3 		– Sell
-10
Closed -$187 – 3230
2025
Q2 		$187 Hold
10
– – ﹤0.01% 2939
2025
Q1 		$180 Buy
+10
New +$203 ﹤0.01% 2875

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Rothschild Investment LLC's RIGL Position: Q2 2026 in Review

Rothschild Investment LLC increased its Rigel Pharmaceuticals (RIGL) stake by 5,100% in Q2 2026, buying an estimated $1.57K and bringing the position to 52 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2759.

Rothschild Investment LLC first reported a position in RIGL in Q1 2025 and has held it in 5 quarters since. 46 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Rothschild Investment LLC held 52 shares of Rigel Pharmaceuticals worth $2.03K as of Q2 2026.
  • Rothschild Investment LLC bought 51 Rigel Pharmaceuticals shares in Q2 2026, an estimated $1.57K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2759 holding.
  • Rothschild Investment LLC first reported a position in Rigel Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 46 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.